VIR-165 is a modified form of virus inhibitory peptide (VIRIP) that binds the fusion peptide of the gp41 subunit and prevents its insertion into the target membrane. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains.
CAT# | R1750 |
M.F/Formula | C₁₀₉H₁₅₈N₂₂O₂₅S₂ |
M.W/Mr. | 2240.70 |
Sequence | One Letter Code: LEAIPCSIPPCFAFNKPFVF (Disulfide bridge: Cys6-Cys11) three Letter Code: Leu-Glu-Ala-Ile-Pro-Cys-Ser-Ile-Pro-Pro-Cys-Phe-Ala-Phe-Asn-Lys-Pro-Phe-Val-Phe (Disulfide bridge: Cys6-Cys11) |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The endocytosis of AMPA receptors (AMPARs) requires the GTPase activity of dynamin. Since it is now established ...
In 1979, GOLDSTEIN et al. extracted an opioid-active 17 peptide from the pituitary of pigs and named it dynorphi ...
Glucagon-like peptide-1 (GLP-1) and glucose-depended insulinotropic polypeptide (GIP) are the two peptides that have been con ...
Protirelin is also known as thyrotropin releasing hormone (TRH), a peptide hormone secreted by the hypothalamus. ...
Ganirelix, a synthetic decapeptide compound, is a gonadotrophin-releasing hormone (GnRH) antagonist preparation ...